CRS+HIPEC in other gynecological tumors(II):

16.6: CRS+HIPEC: peritoneal recurrence of borderline ovarian cancer

16.7: CRS+HIPEC in endometrial cancer recurrence (surgery and previous RDT)

16.8: CRS+HIPEC in primary peritoneal cancer recurrence

16.9: CRS+HIPEC in recurrence of endocervical mucinous adenocarcinoma

16.10: CRS+HIPEC in uterine sarcoma

16.11: CRS+HIPEC in the recurrence of immature teratoma (G2)